1. |
皇甫镜如. 白内障术后黄斑水肿的诊治新进展[J]. 中华实验眼科杂志, 2019, 37(4): 312-315. DOI: 10.3760/cma.j.issn.2095-0160.2019.04.016.Huangfu JR. New progress of diagnosis and treatment in pseudophakic cystoid macular edema[J]. Chin J Exp Ophthalmol, 2019, 37(4): 312-315. DOI: 10.3760/cma.j.issn.2095-0160.2019.04.016.
|
2. |
谢茂松, 徐国兴. Irvine-Gass综合征的发病机制[J]. 国际眼科纵览, 2007, 31(3): 183-185. DOI: 10.3760/cma.j.issn.1673-5803.2007.03.011.Xie MS, Xu GX. The pathogenesis of Irvine-Gass syndrome[J]. Int Rev Ophthalmol, 2007, 31(3): 183-185. DOI: 10.3760/cma.j.issn.1673-5803.2007.03.011.
|
3. |
Mantes J, Erakglm T, Afrashi F, et al. Inddenee of cystoid rnacu1ar edema after uncomplicated phacoemulsification[J]. Ophthalmologica, 2003, 217(6): 408-412. DOI: 10.1159/000073070.
|
4. |
Vyas S, Thapa R, Bajimaya S, et al. Anatomical and visual outcome of intravitreal bevacizumab (Avastin) in patients with diabetic macular edema[J]. Nepal J Ophthalmol, 2016, 8(15): 54-61. DOI: 10.3126/nepjoph.v8i1.16157.
|
5. |
Grzybowski A, Sikorski BL, Ascaso FJ, et al. Pseudophakic cystoid macular edema: update 2016[J]. Clin Interv Aging, 2016, 11: 1221-1229. DOI: 10.2147/CIA.S111761.
|
6. |
Demirel S, Batioğlu F, Özmert E. Intravitreal ranibizumab for the treatment of cystoid macular edema in Irvine-Gass syndrome[J]. J Ocul Pharmacol Ther, 2012, 28(6): 636-639. DOI: 10.1089/jop.2012.0032.
|
7. |
Arevalo JF, Maia M, Garcia-Amaris RA, et al. Intravitreal bevacizumab for refractory pseudophakic cystoid macular edema: the Pan-American Collaborative Retina Study Group results[J]. Ophthalmology, 2009, 116(8): 1481-1487. DOI: 10.1016/j.ophtha.2009.04.006.
|
8. |
赵宏锟, 邹悦, 李云琴. 阈下微脉冲激光在眼科疾病治疗中的应用[J]. 国际眼科杂志, 2020, 20(1): 92-95. DOI: 10.3980/j.issn.1672-5123.2020.1.21.Zhao HK, Zou Y, Li YQ. Application of subthreshold micro pulse laser in the treatment of ophthalmic diseases[J]. Int Eye Sci, 2020, 20(1): 92-95. DOI: 10.3980/j.issn.1672-5123.2020.1.21.
|
9. |
Gawęcki M. Micropulse laser treatment of retinal diseases[J/OL]. J Clin Med, 2019, 13, 8(2): 242[2019-02-13]. https://pubmed.ncbi.nlm.nih.gov/30781780/. DOI: 10.3390/jcm8020242.
|
10. |
褚煜, 喻晓兵, 卢建民. 577 nm微脉冲激光治疗黄斑水肿的疗效观察[J]. 中国激光医学杂志, 2018, 27(6): 375-379. DOI: 10.13480/j.issn1003-9430.2018.0375.Chu Y, Yu XB, Lu JM. Efficacy of subthreshold micropulse yellow laser (577 nm) photocoagulation for macular edema[J]. Chin J Laser Med Surg, 2018, 27(6): 375-379. DOI: 10.13480/j.issn1003-9430.2018.0375.
|
11. |
Levitz L, Reich J, Roberts TV, et al. Incidence of cystoid macular edema: femtosecond laser-assisted cataract surgery versus manual cataract surgery[J]. J Cataract Refract Surg, 2015, 41(3): 683-686. DOI: 10.1016/j.jcrs.2014.11.039.
|
12. |
曲迎新. 非甾体类抗炎药预防白内障术后黄斑囊样水肿的研究进展[J]. 临床和实验医学杂志, 2009, 8(4): 137-139. DOI: 10.3969/j.issn.1671-4695.2009.04.096.Qu YX. Research progress of non steroidal anti-inflammatory drugs in preventing cystoid macular edema after cataract surgery[J]. Journal of Clinical and Experimental Medicine, 2009, 8(4): 137-139. DOI: 10.3969/j.issn.1671-4695.2009.04.096.
|
13. |
祁媛媛, 祝莹, 徐少凯, 等. 玻璃体内注射康柏西普治疗Irvine-Gass综合征[J]. 中华眼外伤职业眼病杂志, 2018, 40(1): 59-62. DOI: 10.3760/cma.j.issn.2095-1477.2018.01.016.Qi YY, Zhu Y, Xu SK, et al. Intravitreal injection of conbercept in the treatment of Irvine-Gass syndrome[J]. Chin J Ocul Traum Occupat Eye Dis, 2018, 40(1): 59-62. DOI: 10.3760/cma.j.issn.2095-1477.2018.01.016.
|
14. |
Harbour JW, Smiddy WE, Rubsamen PE, et al. Pars plana vitrectomy for chronic pseudophakic cystoid macular edema[J]. Am J Ophthalmol, 1995, 120(3): 302-307. DOI: 10.1016/S0002-9394(14)72159-2.
|
15. |
Falavarjani KG, Nguyen QD. Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature[J]. Eye (Lond), 2013, 27(7): 787-794. DOI: 10.1038/eye.2013.107.
|
16. |
Cho H, Madu A. Etiology and treatment of the inflammatory causes of cystoid macular edema[J]. J Inflamm Res, 2009, 2: 37-43. DOI: 10.2147/jir.s5706.
|
17. |
连海燕, 陈晓, 闫明, 等. 阈值下微脉冲激光光凝治疗黄斑疾病的研究现状和进展[J]. 中华眼底病杂志, 2019, 35(2): 206-210. DOI: 10.3760/cma.j.issn.1005-1015.2019.02.020.Lian HY, Chen X, Yan M, et al. Research status and progress of threshold micropulse laser photocoagulation in the treatment of macular diseases[J]. Chin J Ocul Fundus Dis, 2019, 35(2): 206-210. DOI: 10.3760/cma.j.issn.1005-1015.2019.02.020.
|
18. |
Mansouri A, Sampat KM, Malik KJ, et al. Efficacy of subthreshold micropulse laser in the treatment of diabetic macular edema is influenced by pre-treatment central foveal thickness[J]. Eye (Lond), 2014, 28(12): 1418-1424. DOI: 10.1038/eye.2014.264.
|
19. |
Keunen JEE, Battaglia-Parodi M, Vujosevic S, et al. International retinal laser society guidelines for subthreshold laser treatment[J/OL]. Transl Vis Sci Technol, 2020, 9(9): 15[2020-08-07]. https://pubmed.ncbi.nlm.nih.gov/32879771/. DOI: 10.1167/tvst.9.9.15.
|
20. |
Sholz P, Altay L, Fauser S. A review of subthreshold micropulse laser for treatment of macular disorders[J]. Adv Ther, 2017, 34(7): 1528-1555. DOI: 10.3390/jcm8020242.
|
21. |
张风, 张斯桦. 多波长精确治疗: 眼底病激光治疗的发展方向[J]. 中华眼底病杂志, 1997, 13(4): 209.Zhang F, Zhang SH. Multi wavelength precision therapy: the development direction of laser therapy for fundus diseases[J]. Chin J Ocul Fundus Dis, 1997, 13(4): 209.
|